Rosmantuzumab

Rosmantuzumab
Monoclonal antibody
Type?
SourceHumanized (from mouse)
TargetRSPO3
Clinical data
Other namesOMP-131R10
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6456H9954N1714O2048S46
Molar mass145825.36 g·mol−1

Rosmantuzumab (INN; development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer.

This drug was developed by OncoMed Pharmaceuticals.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.